Please enable JavaScript to continue using this application.

Compare $KRRO vs $NBP | Chartloom

Compare

$KRRO vs $NBP

Korro Bio Inc · NovaBridge Biosciences

KRRO

Korro Bio Inc

NBP

NovaBridge Biosciences

Compare $KRRO vs $NBP

Comparing Korro Bio Inc and NovaBridge Biosciences

KRROKorro Bio Inc

NBPNovaBridge Biosciences

KRROKorro Bio Inc

Market cap

$147M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

143.63x

Rev growth (TTM)

-62.1%

YTD performance

26.2%

52W performance

-77.8%

FCF yield

-46.6%

NBPNovaBridge Biosciences

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-72.5%

FCF yield

-33.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KRRO

NBP

Detailed metrics comparison

KRRO

Korro Bio Inc

NBP

NovaBridge Biosciences

Market Cap

KRRO$147M

NBP$161M

Enterprise Value

KRRO$122M

NBP$-30M

Price

KRRO$10.16

NBP$1.40

P/E Ratio

KRRON/A

NBPN/A

P/S Ratio

KRRO61.51x

NBP3.29x

EV/Sales

KRRO51.05x

NBP0.00x

EV/EBITDA

KRRO0.00x

NBP0.00x

P/B Ratio

KRRO1.38x

NBP0.77x

P/FCF Ratio

KRRON/A

NBPN/A

EV/FCF

KRRO-1.78x

NBP0.55x

PEG Ratio

KRRON/A

NBPN/A

Forward P/E (NTM)

KRRON/A

NBPN/A

Forward P/S (NTM)

KRRO143.63x

NBPN/A

Revenue (TTM)

KRRO$2M

NBP$0

Revenue Growth (YoY)

KRRO-62.1%

NBPN/A

Forward Rev Growth

KRRO240.0%

NBP419.8%

Gross Margin (TTM)

KRRO0.0%

NBP100.0%

Operating Margin (TTM)

KRRO0.0%

NBP0.0%

EBITDA Margin (TTM)

KRRO-3068.6%

NBP0.0%

Net Margin (TTM)

KRRO-4477.1%

NBP0.0%

FCF Margin (TTM)

KRRO-2865.9%

NBPN/A

Net Income (TTM)

KRRO$-107M

NBP$-43M

FCF (TTM)

KRRO$-68M

NBP$-55M

EPS (TTM)

KRRO-$6.05

NBP$0.00

ROE (TTM)

KRRO-11426.0%

NBP-2091.0%

ROA (TTM)

KRRO-6857.0%

NBP-1941.0%

ROIC (TTM)

KRRO-11426.0%

NBP-2091.0%

Cash

KRRO$25M

NBP$191M

Debt

KRRO$0

NBP$0

Net Cash/Debt

KRRO$25M

NBP$191M

Current Ratio (TTM)

KRRO9.55x

NBP7.64x

Quick Ratio (TTM)

KRRO9.11x

NBP7.60x

Debt/Equity (TTM)

KRRO0.00x

NBP0.00x

Debt/Assets (TTM)

KRRO0.0%

NBP0.0%

Interest Coverage (TTM)

KRRON/A

NBPN/A

Net Debt/EBITDA (TTM)

KRRO0.00x

NBP0.00x

Beta

KRRO3.27

NBP1.69

52W Performance

KRRO-77.8%

NBP-72.5%

YTD Performance

KRRO26.2%

NBP-67.3%

% from 52W High

KRRO-81.8%

NBP-79.5%

% from 52W Low

KRRO95.2%

NBP6.5%

Asset Turnover (TTM)

KRRO0.04x

NBP0.11x

FCF Yield (TTM)

KRRO-46.6%

NBP-33.9%

Earnings Yield (TTM)

KRRO-72.8%

NBP-26.8%

Dividend Yield (TTM)

KRRON/A

NBPN/A

Rule of 40

KRRO-2,927.9

NBP0.0

EV/GP/RG

KRRON/A

NBPN/A

Ticker research

View KRRO research View NBP research

Metric	KRRO Korro Bio Inc	NBP NovaBridge Biosciences
Market & Valuation
Market Cap	$147M	$161M
Enterprise Value	$122M	$-30M
Price	$10.16	$1.40
P/E Ratio	N/A	N/A
P/S Ratio	61.51x	3.29x
EV/Sales	51.05x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.78x	0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	143.63x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-62.1%	N/A
Forward Rev Growth	240.0%	419.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3068.6%	0.0%
Net Margin (TTM)	-4477.1%	0.0%
FCF Margin (TTM)	-2865.9%	N/A
Net Income (TTM)	$-107M	$-43M
FCF (TTM)	$-68M	$-55M
EPS (TTM)	-$6.05	$0.00
ROE (TTM)	-11426.0%	-2091.0%
ROA (TTM)	-6857.0%	-1941.0%
ROIC (TTM)	-11426.0%	-2091.0%
Financial Health
Cash	$25M	$191M
Debt	$0	$0
Net Cash/Debt	$25M	$191M
Current Ratio (TTM)	9.55x	7.64x
Quick Ratio (TTM)	9.11x	7.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.27	1.69
52W Performance	-77.8%	-72.5%
YTD Performance	26.2%	-67.3%
% from 52W High	-81.8%	-79.5%
% from 52W Low	95.2%	6.5%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.11x
FCF Yield (TTM)	-46.6%	-33.9%
Earnings Yield (TTM)	-72.8%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,927.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KRRO research	View NBP research

Valuation

P/S Ratio

NBP

3.29x

KRRO

61.51x

EV/FCF

KRRO

-1.78x

NBP

0.55x

Growth & revenue

Revenue Growth TTM

KRRO

-62.1%

Forward Revenue Growth

NBP

419.8%

KRRO

240.0%

Profitability & performance

Gross Margin

NBP

100.0%

KRRO

0.0%

ROE

NBP

-2091.0%

KRRO

-11426.0%

FCF Yield %

NBP

-33.9%

KRRO

-46.6%

52-Week Performance

NBP

-72.5%

KRRO

-77.8%

Detailed metrics comparison

KRRO

Korro Bio Inc

NBP

NovaBridge Biosciences

Market Cap

KRRO$147M

NBP$161M

Enterprise Value

KRRO$122M

NBP$-30M

Price

KRRO$10.16

NBP$1.40

P/E Ratio

KRRON/A

NBPN/A

P/S Ratio

KRRO61.51x

NBP3.29x

EV/Sales

KRRO51.05x

NBP0.00x

EV/EBITDA

KRRO0.00x

NBP0.00x

P/B Ratio

KRRO1.38x

NBP0.77x

P/FCF Ratio

KRRON/A

NBPN/A

EV/FCF

KRRO-1.78x

NBP0.55x

PEG Ratio

KRRON/A

NBPN/A

Forward P/E (NTM)

KRRON/A

NBPN/A

Forward P/S (NTM)

KRRO143.63x

NBPN/A

Revenue (TTM)

KRRO$2M

NBP$0

Revenue Growth (YoY)

KRRO-62.1%

NBPN/A

Forward Rev Growth

KRRO240.0%

NBP419.8%

Gross Margin (TTM)

KRRO0.0%

NBP100.0%

Operating Margin (TTM)

KRRO0.0%

NBP0.0%

EBITDA Margin (TTM)

KRRO-3068.6%

NBP0.0%

Net Margin (TTM)

KRRO-4477.1%

NBP0.0%

FCF Margin (TTM)

KRRO-2865.9%

NBPN/A

Net Income (TTM)

KRRO$-107M

NBP$-43M

FCF (TTM)

KRRO$-68M

NBP$-55M

EPS (TTM)

KRRO-$6.05

NBP$0.00

ROE (TTM)

KRRO-11426.0%

NBP-2091.0%

ROA (TTM)

KRRO-6857.0%

NBP-1941.0%

ROIC (TTM)

KRRO-11426.0%

NBP-2091.0%

Cash

KRRO$25M

NBP$191M

Debt

KRRO$0

NBP$0

Net Cash/Debt

KRRO$25M

NBP$191M

Current Ratio (TTM)

KRRO9.55x

NBP7.64x

Quick Ratio (TTM)

KRRO9.11x

NBP7.60x

Debt/Equity (TTM)

KRRO0.00x

NBP0.00x

Debt/Assets (TTM)

KRRO0.0%

NBP0.0%

Interest Coverage (TTM)

KRRON/A

NBPN/A

Net Debt/EBITDA (TTM)

KRRO0.00x

NBP0.00x

Beta

KRRO3.27

NBP1.69

52W Performance

KRRO-77.8%

NBP-72.5%

YTD Performance

KRRO26.2%

NBP-67.3%

% from 52W High

KRRO-81.8%

NBP-79.5%

% from 52W Low

KRRO95.2%

NBP6.5%

Asset Turnover (TTM)

KRRO0.04x

NBP0.11x

FCF Yield (TTM)

KRRO-46.6%

NBP-33.9%

Earnings Yield (TTM)

KRRO-72.8%

NBP-26.8%

Dividend Yield (TTM)

KRRON/A

NBPN/A

Rule of 40

KRRO-2,927.9

NBP0.0

EV/GP/RG

KRRON/A

NBPN/A

Ticker research

View KRRO research View NBP research

Metric	KRRO Korro Bio Inc	NBP NovaBridge Biosciences
Market & Valuation
Market Cap	$147M	$161M
Enterprise Value	$122M	$-30M
Price	$10.16	$1.40
P/E Ratio	N/A	N/A
P/S Ratio	61.51x	3.29x
EV/Sales	51.05x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.78x	0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	143.63x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-62.1%	N/A
Forward Rev Growth	240.0%	419.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3068.6%	0.0%
Net Margin (TTM)	-4477.1%	0.0%
FCF Margin (TTM)	-2865.9%	N/A
Net Income (TTM)	$-107M	$-43M
FCF (TTM)	$-68M	$-55M
EPS (TTM)	-$6.05	$0.00
ROE (TTM)	-11426.0%	-2091.0%
ROA (TTM)	-6857.0%	-1941.0%
ROIC (TTM)	-11426.0%	-2091.0%
Financial Health
Cash	$25M	$191M
Debt	$0	$0
Net Cash/Debt	$25M	$191M
Current Ratio (TTM)	9.55x	7.64x
Quick Ratio (TTM)	9.11x	7.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.27	1.69
52W Performance	-77.8%	-72.5%
YTD Performance	26.2%	-67.3%
% from 52W High	-81.8%	-79.5%
% from 52W Low	95.2%	6.5%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.11x
FCF Yield (TTM)	-46.6%	-33.9%
Earnings Yield (TTM)	-72.8%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,927.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KRRO research	View NBP research